Nevertheless, in recent years, an increased p62 expression has been documented mainly in high grade gliomas without any relationship with isocitrate dehydrogenase (IDH) mutation status [15, 26, 27]. The gene discussed is SQSTM1; the disease is central nervous system cancer.